Delivery Order SPE2DR25D3013-SPE2DR26F6S5P
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,662.57 on September 16, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency has awarded a delivery order valued at $11,236.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for Tagrisso 80 mg tablets (30-count supply) under a firm fixed-price contract. The award was issued on September 15, 2025, with an ultimate completion date of October 6, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement to support federal medical supply needs....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a contract value of $21,325.16. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by November 19, 2025, with performance conducted at the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Tagrisso 80 mg tablets (30-count packages) with a ceiling value of $21.3K. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Tagrisso 40 mg tablets (30-count units) with a ceiling value of $10,641.07. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for the supply of Tagrisso 40 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 24, 2025. The award was made on September 3, 2025, with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tagrisso 80 mg tablets (30-count packaging). This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order is scheduled for completion by December 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $63,889.44 to AmerisourceBergen Drug Corp for the supply of Tagrisso 40 mg tablets (30-count) on October 27, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is being performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract. The order, issued on April 23, 2025, with an ultimate completion date of May 14, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this delivery order as a child contract under a...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6S5PDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Tagrisso 40 mg tablets (30-count) with a ceiling value of $11,214.04. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. The order is scheduled for completion by December 9, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that serves as the comprehensive global pharmaceutical support mechanism for military healthcare systems. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, maintains a significant presence in federal medical procurement through its DLA contract vehicle, which enables the company to supply a broad spectrum of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The Tagrisso supply fulfills ongoing military healthcare pharmaceutical needs as part of the company's extensive portfolio of brand-name and generic medications, specialty drugs, and medical commodities. The DLA plans to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving as a critical federal pharmaceutical supplier.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 11/17/25 |